This inventor holds 4 USPTO granted patents and 1 EPO patent. Top assignees: Zeneca Limited, Astrazeneca Ab, Merck Serono S. a.. Active years: 2002-2011.
Company Filing History:
2 out of 854 
1 out of 1,531 
1 out of 145 
Years Active: 2002-2011
Title: The Innovations of Norman Cameron
Introduction
Norman Cameron is a notable inventor based in Aberdeen, GB. He has made significant contributions to the field of medicine, particularly in the treatment of diabetic complications. With a total of 4 patents to his name, Cameron's work has the potential to impact many lives.
Latest Patents
Cameron's latest patents include a method for inhibiting microvascular complications by administering IL-6. This invention relates to the use of IL-6 or its derivatives in addressing microvascular complications. Another significant patent involves the use of 3-hydroxy-3-methylgutaryl coenzyme A reductase inhibitors for the manufacture of a medicament aimed at treating diabetic neuropathy. This invention highlights a new application of statin drugs to improve nerve conduction velocity and blood flow in diabetic patients, particularly when combined with other agents known to enhance diabetic neuropathy.
Career Highlights
Throughout his career, Norman Cameron has worked with prominent companies such as Zeneca Limited and AstraZeneca AB. His experience in these organizations has contributed to his expertise in pharmaceutical innovations.
Collaborations
Cameron has collaborated with notable individuals in his field, including Mary Anne Cotter and Frank Carey. These partnerships have likely enriched his research and development efforts.
Conclusion
Norman Cameron's contributions to medical innovation, particularly in the treatment of diabetic complications, showcase his dedication to improving patient outcomes. His patents reflect a commitment to advancing healthcare through scientific research and collaboration.